Stock listing
6C1 Stock Price, News, Filings & Events — Cytomx Therapeutics, Inc.
Selected listing: 6C1 · BX · CHF · CH
This page tracks Cytomx Therapeutics, Inc.'s 6C1:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6C1:BX. 6C1:BX is the stock-level entry point for investors researching Cytomx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 6C1:BX
- Asset type
- Stock
- Market cap
- $699.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX
- Currency
- CHF
Cytomx Therapeutics, Inc. 6C1:BX stock context
This page tracks Cytomx Therapeutics, Inc.'s 6C1:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6C1:BX. 6C1:BX is the stock-level entry point for investors researching Cytomx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Cytomx Therapeutics, Inc.
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colore...
August 27, 2026
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
August 3, 2026
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
July 27, 2026
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the...
June 3, 2026
Cytomx Therapeutics, Inc. earnings calls
CytomX Therapeutics, Inc. (CTMX) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call
March 16, 2026 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Research Cytomx Therapeutics, Inc.
Cytomx Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for 6C1:BX.
Cytomx Therapeutics, Inc. company profile
View the public company page for Cytomx Therapeutics, Inc. on 6ix.
Cytomx Therapeutics, Inc. news
Read company news and market updates connected to Cytomx Therapeutics, Inc..
Cytomx Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Cytomx Therapeutics, Inc..
Alternate listings
CTMX:NASDAQ
US · USD
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
6C1:GETTEX
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
A14158:LSX
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
A14158:LS
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
6C1:TRADEGATE
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
6C1:FWB
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
CTMX:BOATS
US · USD
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
6C1:DUS
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.
6C1:SWB
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:BX.